Oncology & Cancer

Scientists explore potential new treatments for glioblastoma

A new approach to treating the most malignant type of brain cancer—glioblastoma—has shown strong promise in pre-clinical settings, raising hopes of increasing current average survival rates beyond 18 months.

Oncology & Cancer

New antibody harbors great potential for fighting blood cancer

Acute lymphoblastic leukemia (ALL) is the most common cancer in children. This form of blood cancer, which also occurs in adults, is caused by malignantly degenerated precursor cells of certain white blood cells (B-cell precursors ...

page 6 from 8